1012P First-in-human study of ABSK-011, a novel, highly selective fibroblast growth factor receptor (FGFR) 4 inhibitor for treating advanced hepatocellular carcinoma (HCC) with FGF19 overexpression

A-L. Cheng,C-J. Yen, Q. Cheng,C-C. Lin, P. Huang,D. Li,Y. Li, J. Wang, M. Sun, Q. Wen, S. Gu, X. Du, J. Qian,C. Liu, F. Zhang, C. Dai, G. Li, X. Ding,J. Liu,X-P. Chen

Annals of Oncology(2023)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要